Notice Title

Consent to the Distribution of New Medicines

Publication Date
30 Jan 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go458
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Zantac (General sale)
Active Ingredient: Ranitidine hydrochloride 168mg equivalent to ranitidine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Manufacturer: Strides Pharma Science Limited, Periyakalapet, India
   
Product: Zantac (Pharmacy only)
Active Ingredient: Ranitidine hydrochloride 168mg equivalent to ranitidine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Manufacturer: Strides Pharma Science Limited, Periyakalapet, India
   
Product: Zantac Double Strength
Active Ingredient: Ranitidine hydrochloride 336mg equivalent to ranitidine 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Manufacturer: Strides Pharma Science Limited, Periyakalapet, India


Dated this 24th day of January 2025.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).